Sphaera Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 9.25 Cr
as on 02-07-2024
- Company Age 17 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -53.04%
(FY 2023)
- Profit -583.13%
(FY 2023)
- Ebitda -477.56%
(FY 2023)
- Net Worth -98.42%
(FY 2023)
- Total Assets -78.16%
(FY 2023)
About Sphaera Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sphaera Pharma Private Limited India is Kritika Chhabra as COMPANY SECRETARY. Ashish Dugar, Somdutta Sen, and Abhinav Dhandia serve as directors at the Company.
- CIN/LLPIN
U24232DL2007PTC224934
- Company No.
224934
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Nov 2007
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sphaera Pharma Private Limited offer?
Sphaera Pharma Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Medical Treatment Services, Pain Clinic Services, Medical Surgery Services, Corporate and Soft Skills Training, Corporate Training.
Who are the key members and board of directors at Sphaera Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kritika Chhabra | Company Secretary | 03-Jul-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Dugar  | Director | 02-Dec-2022 | Current |
| Somdutta Sen | Director | 02-Dec-2022 | Current |
| Abhinav Dhandia | Director | 21-Feb-2019 | Current |
Financial Performance and Corporate Structure Insights of Sphaera Pharma.
Sphaera Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.04% decrease. The company also saw a substantial fall in profitability, with a 583.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 98.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sphaera Pharma?
In 2022, Sphaera Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sphaera Pharma Research And Development Private LimitedActive 16 years 21 daysAshish Dugar and Abhinav Dhandia are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sphaera Pharma?
Sphaera Pharma has a workforce of 43 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sphaera Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sphaera Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
